Spyglass Pharma, Inc. · NASDAQ:SGP
New Enterprise Associates 17, L.P. reported a 22.20% stake in Spyglass Pharma, Inc. (Schedule 13D)
Event Feb 9, 2026 · Filed Feb 13, 2026
New Enterprise Associates 17, L.P. reported a 22.20% stake in Spyglass Pharma, Inc., 7,392,301 shares, with active intent on Feb 9, 2026. Filed Feb 13, 2026 (Schedule 13D).
- Stake
- 22.20%
- Shares
- 7,392,301
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 15 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| New Enterprise Associates 17, L.P. | 22.20% | 7,392,301 |
| NEA Partners 17, L.P. | 22.20% | 7,392,301 |
| NEA 17 GP, LLC | 22.20% | 7,392,301 |
| New Enterprise Associates 16, L.P. | 22.20% | 7,392,301 |
| NEA Partners 16, L.P. | 22.20% | 7,392,301 |
| NEA 16 GP, LLC | 22.20% | 7,392,301 |
| Forest Baskett | 22.20% | 7,392,301 |
| Ali Behbahani | 22.20% | 7,393,823 |
| Carmen Chang | 22.20% | 7,392,301 |
| Anthony A. Florence, Jr. | 22.20% | 7,392,301 |
| Mohamad H. Makhzoumi | 22.20% | 7,392,301 |
| Edward T. Mathers | 18.10% | 6,035,038 |
| Scott D. Sandell | 22.20% | 7,392,301 |
| Paul Walker | 22.20% | 7,392,301 |
| Rick Yang | 18.10% | 6,035,038 |
Source
Related
- Spyglass Pharma, Inc.
- New Enterprise Associates 17, L.P.
- Spyglass Pharma, Inc. shareholders
- Schedule 13D · Ra Capital Management, L.P. · Feb 17, 2026
- Schedule 13G · Srinivas Akkaraju · Feb 17, 2026
- Schedule 13D · Gilde Healthcare Holding B.V. · Feb 13, 2026
- Schedule 13G · Sands Frank M. · Feb 13, 2026
- Schedule 13D · Vensana Capital I GP, LLC · Feb 10, 2026